Hospital
Emanate Health Medical Center
Emanate Health Medical Center was paid $23.44M by Medicaid between Jan 2018 and Dec 2024, across 393 billing codes. Its largest line is 0450, Emergency room services — 23% of everything it billed.
33Billing provider infoEMANATE HEALTH MEDICAL CENTER
WEST COVINA, CA 91790
WEST COVINA, CA 91790
33aNPI1063441293assigned 07/01/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$23.44M
24GClaims1,513,507
24DCodes billed393
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#110 of 410
Median peer was paid$6.90M
This provider vs. median3.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 174,508 | $3.05M | |
| 2019 | 182,516 | $2.79M | |
| 2020 | 167,810 | $2.31M | |
| 2021 | 177,045 | $2.91M | |
| 2022 | 226,735 | $3.90M | |
| 2023 | 290,990 | $4.67M | |
| 2024incomplete | 293,903 | $3.81M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 23% | 129,465 | 116,671 | $5.40M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.7% | 10,405 | 10,079 | $875K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.3% | 10,319 | 10,006 | $775K |
| Z7502 | 2.9% | 18,184 | 18,034 | $683K | |
| 99199 | Unlisted special service, procedure or report | 2.7% | 27,497 | 23,816 | $641K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.6% | 36,196 | 33,204 | $617K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.6% | 33,483 | 30,245 | $603K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 2.6% | 2,646 | 2,597 | $600K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.3% | 3,783 | 3,649 | $548K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.0% | 11,451 | 10,651 | $470K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.0% | 7,190 | 6,622 | $468K |
| 80053 | Comprehensive metabolic panel | 1.7% | 69,503 | 63,753 | $387K |
381 more codes
| 0762 | 1.7% | 7,847 | $387K | |
| Z7500 | 1.5% | 10,394 | $354K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.5% | 29,305 | $345K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.4% | 7,220 | $335K |
| 99285 | Emergency room visit (most serious) | 1.3% | 1,816 | $315K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 81,789 | $315K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 1.3% | 6,839 | $314K |
| 71045 | Radiologic examination, chest; single view | 1.3% | 30,466 | $298K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.2% | 5,684 | $282K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1.1% | 16,439 | $260K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 1.1% | 26,142 | $249K |
| 0510 | 1.0% | 29,180 | $236K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 6,846 | $231K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 6,440 | $229K |
| J3490 | Unclassified drugs | <1% | 48,927 | $220K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 1,496 | $207K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 4,516 | $180K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 5,120 | $179K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 1,249 | $171K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 1,680 | $166K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 8,419 | $161K |
| 76801 | <1% | 3,909 | $161K | |
| 97139 | <1% | 11,254 | $159K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 4,098 | $144K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 3,323 | $134K |
| 93971 | <1% | 1,835 | $130K | |
| 0360 | <1% | 3,269 | $129K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 23,704 | $129K |
| 99284 | Emergency room visit (serious) | <1% | 1,344 | $120K |
| 84484 | <1% | 19,506 | $119K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,663 | $108K |
| 76830 | Ultrasound, transvaginal | <1% | 3,070 | $105K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 7,835 | $105K |
| 0250 | <1% | 37,197 | $103K | |
| 0760 | <1% | 10,706 | $97K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 2,262 | $97K |
| 83690 | <1% | 20,880 | $93K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 2,897 | $92K |
| 0270 | <1% | 23,007 | $85K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 14,041 | $81K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 7,692 | $79K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 8,333 | $77K |
| 0160 | <1% | 2,047 | $77K | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | <1% | 2,654 | $74K |
| 90715 | <1% | 3,425 | $74K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 4,480 | $73K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 9,202 | $70K |
| 81025 | <1% | 19,349 | $70K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 8,550 | $67K |
| 83880 | <1% | 3,741 | $66K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 17,272 | $64K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 10,265 | $64K |
| 93970 | <1% | 519 | $60K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 1,382 | $60K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 963 | $60K |
| 81001 | <1% | 31,019 | $55K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 15,178 | $54K |
| 82803 | <1% | 5,692 | $54K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 3,527 | $50K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 1,215 | $49K |
| Z9725 | <1% | 1,108 | $48K | |
| 73610 | <1% | 3,146 | $48K | |
| 70486 | <1% | 595 | $47K | |
| 73630 | <1% | 3,434 | $46K | |
| 0301 | <1% | 1,338 | $45K | |
| 73564 | <1% | 2,299 | $44K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,368 | $44K |
| 87040 | <1% | 5,398 | $43K | |
| 59025 | Fetal non-stress test | <1% | 4,207 | $42K |
| 0637 | <1% | 12,391 | $41K | |
| 73030 | <1% | 2,715 | $39K | |
| 84702 | <1% | 5,330 | $39K | |
| 84999 | <1% | 267 | $39K | |
| 20610 | <1% | 750 | $38K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 4,990 | $37K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 923 | $36K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 6,498 | $35K |
| 72131 | <1% | 455 | $35K | |
| 73130 | <1% | 2,066 | $34K | |
| G0109 | Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes | <1% | 1,057 | $34K |
| Z7610 | <1% | 4,691 | $31K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,302 | $31K |
| 97803 | <1% | 1,443 | $31K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,556 | $28K |
| S3620 | Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) | <1% | 287 | $27K |
| 73110 | <1% | 1,689 | $27K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 6,154 | $26K |
| 81003 | <1% | 21,587 | $26K | |
| 73502 | <1% | 1,223 | $26K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 5,149 | $25K |
| 83605 | <1% | 3,488 | $25K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 57 | $24K |
| 72100 | <1% | 1,428 | $24K | |
| 0420 | <1% | 1,370 | $24K | |
| 0761 | <1% | 1,528 | $24K | |
| 0942 | <1% | 354 | $23K | |
| 82731 | <1% | 737 | $22K | |
| 97802 | <1% | 497 | $21K | |
| 73562 | <1% | 1,401 | $21K | |
| 97750 | <1% | 960 | $21K | |
| J1815 | Injection, insulin, per 5 units | <1% | 833 | $21K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,031 | $21K |
| 0710 | <1% | 2,410 | $21K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 723 | $20K |
| 90697 | <1% | 3,539 | $20K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 46,364 | $20K |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 2,585 | $20K |
| 83735 | <1% | 5,378 | $20K | |
| 74018 | <1% | 1,926 | $20K | |
| 73590 | <1% | 1,381 | $19K | |
| 85730 | <1% | 6,312 | $19K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 2,130 | $19K |
| J2704 | Injection, propofol, 10 mg | <1% | 2,120 | $19K |
| 85379 | <1% | 2,808 | $18K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 4,706 | $18K |
| 90677 | <1% | 1,503 | $17K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 257 | $17K |
| 85610 | <1% | 8,294 | $17K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 370 | $17K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 10,372 | $17K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 4,098 | $17K |
| 82550 | <1% | 4,532 | $16K | |
| 87186 | <1% | 3,599 | $16K | |
| 76870 | <1% | 582 | $16K | |
| 90461 | <1% | 7,318 | $16K | |
| 73080 | <1% | 988 | $16K | |
| 88313 | <1% | 1,318 | $16K | |
| 71250 | <1% | 274 | $15K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 5,051 | $14K |
| 70496 | <1% | 90 | $14K | |
| 86900 | <1% | 7,663 | $13K | |
| 0278 | <1% | 497 | $13K | |
| 87276 | <1% | 3,060 | $13K | |
| 73090 | <1% | 988 | $13K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 151 | $12K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 3,658 | $12K |
| 96376 | <1% | 1,062 | $12K | |
| 70498 | <1% | 95 | $12K | |
| 76770 | <1% | 385 | $12K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 485 | $12K |
| 80051 | <1% | 2,813 | $12K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 2,127 | $11K |
| 90681 | <1% | 2,284 | $11K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 2,226 | $11K |
| 90670 | <1% | 3,167 | $11K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 4,626 | $11K |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 4,521 | $11K |
| 90651 | <1% | 978 | $11K | |
| 87275 | <1% | 3,066 | $11K | |
| 71101 | <1% | 477 | $10K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,542 | $10K |
| 97804 | <1% | 713 | $10K | |
| 86850 | <1% | 4,190 | $10K | |
| 84703 | <1% | 2,753 | $9K | |
| 84439 | <1% | 4,875 | $9K | |
| 88312 | <1% | 1,266 | $9K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 68 | $8K |
| 92551 | <1% | 3,210 | $8K | |
| 99153 | Mod sedat endo service >5yrs | <1% | 1,057 | $7K |
| 82962 | <1% | 3,634 | $7K | |
| 90633 | <1% | 2,431 | $6K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 743 | $6K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,144 | $6K |
| 72040 | <1% | 402 | $6K | |
| 87430 | <1% | 967 | $6K | |
| 80061 | Lipid panel | <1% | 12,451 | $6K |
| 0121 | <1% | 123 | $6K | |
| 12001 | <1% | 461 | $5K | |
| 90686 | <1% | 2,217 | $5K | |
| 72128 | <1% | 63 | $5K | |
| 87084 | <1% | 804 | $5K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 940 | $5K |
| 70491 | <1% | 46 | $5K | |
| 90707 | <1% | 1,222 | $4K | |
| 96367 | <1% | 202 | $4K | |
| 73060 | <1% | 299 | $4K | |
| 90716 | <1% | 1,219 | $4K | |
| 0272 | <1% | 2,979 | $4K | |
| 82553 | <1% | 580 | $4K | |
| 72110 | <1% | 242 | $4K | |
| J1953 | Injection, levetiracetam, 10 mg | <1% | 82 | $4K |
| 99070 | <1% | 2,356 | $4K | |
| 73140 | <1% | 370 | $4K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 108 | $4K |
| 86140 | <1% | 2,321 | $4K | |
| 85018 | <1% | 2,901 | $3K | |
| 0370 | <1% | 1,029 | $3K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 795 | $3K |
| 74019 | <1% | 213 | $3K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 4,877 | $3K |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 463 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 9,433 | $3K |
| 90700 | <1% | 1,109 | $3K | |
| 90648 | <1% | 1,376 | $3K | |
| 12011 | <1% | 161 | $3K | |
| 87339 | <1% | 763 | $3K | |
| 99499 | <1% | 41 | $3K | |
| 0214 | <1% | 94 | $3K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 349 | $3K |
| 73552 | <1% | 175 | $3K | |
| 90674 | <1% | 316 | $3K | |
| 87420 | <1% | 894 | $3K | |
| 90671 | <1% | 921 | $2K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 559 | $2K |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 149 | $2K |
| 73560 | <1% | 294 | $2K | |
| 90620 | <1% | 265 | $2K | |
| G0009 | Administration of pneumococcal vaccine | <1% | 2,202 | $2K |
| 99173 | <1% | 4,049 | $2K | |
| 90710 | <1% | 920 | $2K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 25 | $2K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 245 | $2K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,472 | $2K |
| 80076 | <1% | 701 | $2K | |
| 81000 | <1% | 998 | $2K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 13 | $2K |
| 90696 | <1% | 860 | $2K | |
| 87070 | <1% | 705 | $2K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 110 | $2K |
| 86901 | <1% | 855 | $2K | |
| 85652 | <1% | 2,627 | $2K | |
| 10060 | <1% | 92 | $2K | |
| G9920 | Screening performed and negative | <1% | 1,018 | $2K |
| 82140 | <1% | 200 | $2K | |
| 73620 | <1% | 181 | $1K | |
| 92652 | <1% | 14 | $1K | |
| 84112 | <1% | 314 | $1K | |
| 87340 | <1% | 1,286 | $1K | |
| 71010 | <1% | 90 | $1K | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 140 | $1K |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 94 | $1K |
| 86592 | <1% | 3,940 | $1K | |
| 97799 | <1% | 142 | $1K | |
| 86803 | <1% | 1,246 | $1K | |
| 80074 | <1% | 653 | $1K | |
| 94150 | <1% | 696 | $1K | |
| 82010 | <1% | 239 | $1K | |
| 90734 | <1% | 729 | $1K | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 84 | $1K |
| 71100 | <1% | 65 | $1K | |
| A9270 | Non-covered item or service | <1% | 1,417 | $1K |
| 73120 | <1% | 164 | $1K | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 140 | $1K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 91 | $1K |
| G0378 | Hospital observation service, per hour | <1% | 29 | $1K |
| 92650 | <1% | 41 | $1K | |
| 72141 | <1% | 14 | $1K | |
| 96127 | <1% | 1,229 | $998.18 | |
| 84100 | <1% | 544 | $955.97 | |
| 82728 | <1% | 1,443 | $953.42 | |
| 90746 | <1% | 44 | $915.74 | |
| 0324 | <1% | 318 | $890.71 | |
| 0171 | Inj, epinephrine (belcher) | <1% | 71 | $870.70 |
| 82607 | <1% | 1,628 | $847.95 | |
| 29125 | <1% | 175 | $834.47 | |
| 86703 | <1% | 2,306 | $815.89 | |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | <1% | 146 | $794.68 |
| 88720 | <1% | 161 | $678.14 | |
| 87081 | <1% | 363 | $666.31 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 525 | $632.59 |
| 0636 | <1% | 766 | $589.43 | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 13 | $565.45 |
| 87205 | <1% | 344 | $564.17 | |
| 88304 | <1% | 116 | $563.50 | |
| 86480 | <1% | 724 | $562.45 | |
| 0002A | <1% | 47 | $560.00 | |
| 86920 | <1% | 28 | $549.72 | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 124 | $541.35 |
| 76642 | <1% | 40 | $541.25 | |
| A0429 | Emergency ambulance ride, basic life support | <1% | 13 | $522.61 |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 52 | $491.60 |
| 83540 | <1% | 1,425 | $484.50 | |
| 73000 | <1% | 39 | $473.99 | |
| 83550 | <1% | 1,382 | $464.02 | |
| A4649 | Surgical supply; miscellaneous | <1% | 11,220 | $461.35 |
| 86701 | <1% | 1,009 | $459.19 | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 40 | $459.01 |
| 84550 | <1% | 1,359 | $455.58 | |
| 82746 | <1% | 809 | $451.41 | |
| 29515 | <1% | 79 | $440.29 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 29 | $434.13 |
| 90723 | <1% | 516 | $396.01 | |
| 72072 | <1% | 25 | $361.00 | |
| 72070 | <1% | 26 | $339.26 | |
| 97116 | <1% | 1,252 | $338.23 | |
| 83655 | <1% | 1,570 | $293.75 | |
| 97162 | <1% | 28 | $289.92 | |
| 99152 | <1% | 12 | $270.57 | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 103 | $256.60 |
| 87806 | <1% | 32 | $220.16 | |
| 88342 | <1% | 28 | $214.63 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 16 | $202.60 |
| 73521 | <1% | 12 | $197.96 | |
| H1000 | Prenatal care, at-risk assessment | <1% | 14 | $192.68 |
| 82043 | <1% | 1,936 | $190.68 | |
| 87210 | <1% | 67 | $184.41 | |
| 90474 | <1% | 53 | $180.00 | |
| 87045 | <1% | 82 | $177.86 | |
| 94664 | <1% | 46 | $177.15 | |
| 92552 | <1% | 142 | $175.98 | |
| G9919 | Screening performed and positive and provision of recommendations | <1% | 147 | $174.00 |
| 84153 | <1% | 932 | $162.76 | |
| 76536 | <1% | 38 | $160.88 | |
| 87522 | Neg quan hep c or qual rna | <1% | 51 | $149.24 |
| 96160 | <1% | 1,717 | $147.10 | |
| 90698 | <1% | 201 | $144.01 | |
| J3105 | Injection, terbutaline sulfate, up to 1 mg | <1% | 16 | $134.50 |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 15 | $131.97 |
| 73100 | <1% | 12 | $125.58 | |
| 99221 | <1% | 1,135 | $115.28 | |
| 12002 | <1% | 12 | $113.40 | |
| 86038 | <1% | 526 | $101.36 | |
| 86235 | <1% | 12 | $98.04 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 301 | $89.50 |
| 84436 | <1% | 157 | $86.98 | |
| 90656 | <1% | 213 | $72.00 | |
| 86225 | <1% | 371 | $69.85 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | <1% | 35 | $67.18 |
| 82570 | <1% | 93 | $63.34 | |
| 86762 | <1% | 155 | $61.47 | |
| 84156 | <1% | 85 | $57.14 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 172 | $50.00 |
| 90473 | <1% | 138 | $43.85 | |
| 86308 | <1% | 19 | $38.77 | |
| 84480 | <1% | 189 | $34.00 | |
| G0008 | Administration of influenza virus vaccine | <1% | 748 | $33.38 |
| 87807 | <1% | 12 | $33.17 | |
| 82784 | <1% | 14 | $30.62 | |
| 82247 | <1% | 15 | $30.23 | |
| 85027 | <1% | 847 | $25.05 | |
| 90661 | <1% | 29 | $25.00 | |
| 83615 | <1% | 46 | $24.23 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 301 | $22.95 |
| 29130 | <1% | 13 | $20.40 | |
| 82378 | <1% | 55 | $19.63 | |
| 86706 | <1% | 88 | $18.90 | |
| 84403 | <1% | 123 | $18.24 | |
| 82951 | <1% | 554 | $15.21 | |
| 86317 | <1% | 99 | $9.80 | |
| 86003 | <1% | 1,037 | $9.45 | |
| 90744 | <1% | 80 | $9.01 | |
| 90381 | <1% | 12 | $9.00 | |
| 82270 | <1% | 601 | $7.27 | |
| 0305 | 0% | 582 | $0.00 | |
| 0112 | 0% | 103 | $0.00 | |
| 0307 | 0% | 328 | $0.00 | |
| 0306 | 0% | 531 | $0.00 | |
| 83001 | 0% | 153 | $0.00 | |
| 87337 | 0% | 44 | $0.00 | |
| 90647 | 0% | 178 | $0.00 | |
| 0310 | 0% | 12 | $0.00 | |
| 0352 | 0% | 58 | $0.00 | |
| 0001A | 0% | 38 | $0.00 | |
| 83002 | 0% | 31 | $0.00 | |
| 90688 | 0% | 21 | $0.00 | |
| 0258 | 0% | 134 | $0.00 | |
| S2900 | Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) | 0% | 13 | $0.00 |
| 99441 | 0% | 17 | $0.00 | |
| Q4051 | Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies) | 0% | 31 | $0.00 |
| 96380 | 0% | 13 | $0.00 | |
| 86431 | 0% | 102 | $0.00 | |
| 81329 | 0% | 272 | $0.00 | |
| 0460 | 0% | 183 | $0.00 | |
| 0302 | 0% | 274 | $0.00 | |
| 82785 | 0% | 414 | $0.00 | |
| 91300 | 0% | 100 | $0.00 | |
| 0320 | 0% | 13 | $0.00 | |
| 0402 | 0% | 103 | $0.00 | |
| 82274 | 0% | 107 | $0.00 | |
| 0300 | 0% | 729 | $0.00 | |
| 0390 | 0% | 303 | $0.00 | |
| 0730 | 0% | 161 | $0.00 | |
| S3005 | Performance measurement, evaluation of patient self assessment, depression | 0% | 375 | $0.00 |
| 90655 | 0% | 30 | $0.00 | |
| 84146 | 0% | 39 | $0.00 | |
| 87481 | 0% | 65 | $0.00 | |
| 82977 | 0% | 15 | $0.00 | |
| 0312 | 0% | 28 | $0.00 | |
| 99218 | 0% | 39 | $0.00 | |
| 86787 | 0% | 12 | $0.00 | |
| 86200 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSHARMA, ROGER (EXECUTIVE VP/CFO)
Parent organizationEMANATE HEALTH
| Provider | Location | Paid |
|---|---|---|
| Emanate Health Medical Center | Covina, CA | $11.22M |
| Emanate Health Foothill Presbyterian Hospital | Glendora, CA | $9.78M |
| Emanate Health Medical Center | Covina, CA | $163K |
| Emanate Health Foothill Presbyterian Hospital | Glendora, CA | $81K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.